About Us
MI-VAD, Inc. is a Rochester, Minnesota based company developing a revolutionary mechanical blood circulatory device or blood pump known as a ventricular assist device (or “VAD”) for heart failure patients that is minimally invasive. A new generation VAD that can significantly reduce heart failure treatment costs while improving patient outcomes will be favorably received in an established worldwide market that in 2017 was estimated at US$1 billion, and is growing annually at a double-digit rate.
The Company was born from our CEO’s experience in managing a team of cardiologists and cardiac surgeons providing mechanical circulatory support therapy and cardiac transplantation to patients at a world leading healthcare institution that has been at the forefront in the delivery of advanced therapy for severe and end-stage heart failure. Consequently, he has significant experience and knowledge of all the currently available VAD platforms. MI-VAD was founded as a result of an awareness of the significant limitations of the currently used VAD platforms, with the aim to create a device that would overcome the clinical shortcomings of the current generation of VADs and would be applicable to all types of heart failure, including both dilated and restrictive cardiomyopathy.
The Company has completed the development of a prototype of its MI-VAD pump device which has undergone preliminary proof of concept testing in a live animal model. This has led to the filing and acquisition of numerous issued patents in the US, Europe, and China with other applications in progress, which will secure maximum protection for our inventions. We are continuing refinement of the pump device and associated elements with the goal of completing the animal studies necessary to support a design freeze leading to investigational implantation.
